Financial
July 11, 2013 at 13:07 PM EDT
Positive Trial Results For Rockwell Medical

Rockwell Medical Inc. (Nasdaq: RMTI) reported positive results from a Phase 3 study of its iron deficiency treatment SFP sending the stock price soaring 90 cents to $4.66.


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here
 
 


 


Advertise with us!